Tandem Diabetes Care Inc TNDM
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2013-11-13 |
| Shares Out. | 68,530,000 |
| Website | tandemdiabetes.com/ ↗ |
| Phone | 13026365400 |
| Employees | 2,500 |
| Revenue | $247.2M |
| Gross Profit | $136.8M |
| Net Income | -$20.4M |
| Free Cash Flow | -$38.8M |
| Total Assets | $1.15B |
| Total Liabilities | $1.02B |
| Equity | $132.4M |
About Tandem Diabetes Care Inc
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Tandem Diabetes Care Inc is a publicly traded company under the ticker symbol TNDM on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
29 analysts (2026-07-01)